All Companies
Ticker MREO
Below our coverage size floor
You reached the page — here's exactly what MREO is, and why it's out of scope for now.
What this ticker is
MREO
Mereo BioPharma Group plc
NASDAQ
Healthcare
Biotechnology
United Kingdom
Mkt cap $46.4M
Mereo BioPharma Group plc ADR is a biopharmaceutical company focused on developing and commercializing therapeutics for rare diseases and oncology. The company’s current portfolio includes product candidates such as setrusumab for osteogenesis imperfecta, alvelestat for alpha-1 antitrypsin deficiency-associated lung disease, and other clinical-stage program…
Why we can't analyze it yet
Below business size floor — market cap $46,390,227 is under our $500,000,000 coverage minimum
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
below_coverage